Cargando…
Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study
The goal of the current study was to explore the potential benefits of Acitretin (Act) nanovesicular gel as a prospective antipsoriatic topical delivery system counteracting the drug challenges in terms of its extremely low aqueous solubility, instability, skin irritation, and serious systemic adver...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824759/ https://www.ncbi.nlm.nih.gov/pubmed/29503541 http://dx.doi.org/10.2147/IJN.S156412 |
_version_ | 1783302077570613248 |
---|---|
author | Abu Hashim, Irhan Ibrahim Abo El-Magd, Noha Fawzy El-Sheakh, Ahmed Ramadan Hamed, Mohammed Fawzy Abd El-Gawad, Abd El-Gawad Helmy |
author_facet | Abu Hashim, Irhan Ibrahim Abo El-Magd, Noha Fawzy El-Sheakh, Ahmed Ramadan Hamed, Mohammed Fawzy Abd El-Gawad, Abd El-Gawad Helmy |
author_sort | Abu Hashim, Irhan Ibrahim |
collection | PubMed |
description | The goal of the current study was to explore the potential benefits of Acitretin (Act) nanovesicular gel as a prospective antipsoriatic topical delivery system counteracting the drug challenges in terms of its extremely low aqueous solubility, instability, skin irritation, and serious systemic adverse effects. Act-loaded niosomes were successfully developed, entirely characterized, and optimized. Further evaluation of the optimized formula was conducted regarding its stability and ex vivo cytotoxicity on different cell lines. The optimized niosomal vesicles were then incorporated in gel base matrix and investigated by sequential ex vivo (skin permeation and deposition) and in vivo (skin irritation and antipsoriatic activity using mouse tail model) experiments. The optimized Act-loaded niosomes (span 60:cholesterol molar ratio 1:1) were spherical in shape and exhibited the highest entrapment efficiency (90.32±3.80%) with appropriate nanosize and zeta potential of 369.73±45.45 nm and −36.33±1.80 mV, respectively. Encapsulation of the drug in the nanovesicles was further emphasized by differential scanning calorimetric and powder X-ray diffraction studies. After 3 months storage at 4±1°C, the optimized formula preserved its stability. Act nano niosomal gel produced a remarkable enhanced ex vivo permeation profile up to 30 h and significant drug deposition in the viable epidermal–dermal layers compared with those of Act gel. The pronounced antipsoriatic activity of the medicated nano niosomes was proved ex vivo in HaCaT cells (a keratinocyte cell line). Topical application of Act nano niosomal gel to mouse tail model further established its distinct in vivo antipsoriatic superiority in terms of significantly higher orthokeratosis, drug activity, and reduction in epidermal thickness compared with the control and other gel formulations. Also, negligible skin irritation and better skin tolerability of Act nanovesicular gel were revealed by primary irritation index and histopathologic examination. |
format | Online Article Text |
id | pubmed-5824759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58247592018-03-02 Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study Abu Hashim, Irhan Ibrahim Abo El-Magd, Noha Fawzy El-Sheakh, Ahmed Ramadan Hamed, Mohammed Fawzy Abd El-Gawad, Abd El-Gawad Helmy Int J Nanomedicine Original Research The goal of the current study was to explore the potential benefits of Acitretin (Act) nanovesicular gel as a prospective antipsoriatic topical delivery system counteracting the drug challenges in terms of its extremely low aqueous solubility, instability, skin irritation, and serious systemic adverse effects. Act-loaded niosomes were successfully developed, entirely characterized, and optimized. Further evaluation of the optimized formula was conducted regarding its stability and ex vivo cytotoxicity on different cell lines. The optimized niosomal vesicles were then incorporated in gel base matrix and investigated by sequential ex vivo (skin permeation and deposition) and in vivo (skin irritation and antipsoriatic activity using mouse tail model) experiments. The optimized Act-loaded niosomes (span 60:cholesterol molar ratio 1:1) were spherical in shape and exhibited the highest entrapment efficiency (90.32±3.80%) with appropriate nanosize and zeta potential of 369.73±45.45 nm and −36.33±1.80 mV, respectively. Encapsulation of the drug in the nanovesicles was further emphasized by differential scanning calorimetric and powder X-ray diffraction studies. After 3 months storage at 4±1°C, the optimized formula preserved its stability. Act nano niosomal gel produced a remarkable enhanced ex vivo permeation profile up to 30 h and significant drug deposition in the viable epidermal–dermal layers compared with those of Act gel. The pronounced antipsoriatic activity of the medicated nano niosomes was proved ex vivo in HaCaT cells (a keratinocyte cell line). Topical application of Act nano niosomal gel to mouse tail model further established its distinct in vivo antipsoriatic superiority in terms of significantly higher orthokeratosis, drug activity, and reduction in epidermal thickness compared with the control and other gel formulations. Also, negligible skin irritation and better skin tolerability of Act nanovesicular gel were revealed by primary irritation index and histopathologic examination. Dove Medical Press 2018-02-20 /pmc/articles/PMC5824759/ /pubmed/29503541 http://dx.doi.org/10.2147/IJN.S156412 Text en © 2018 Abu Hashim et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Abu Hashim, Irhan Ibrahim Abo El-Magd, Noha Fawzy El-Sheakh, Ahmed Ramadan Hamed, Mohammed Fawzy Abd El-Gawad, Abd El-Gawad Helmy Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study |
title | Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study |
title_full | Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study |
title_fullStr | Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study |
title_full_unstemmed | Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study |
title_short | Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study |
title_sort | pivotal role of acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824759/ https://www.ncbi.nlm.nih.gov/pubmed/29503541 http://dx.doi.org/10.2147/IJN.S156412 |
work_keys_str_mv | AT abuhashimirhanibrahim pivotalroleofacitretinnanovesiculargelforeffectivetreatmentofpsoriasisexvivoinvivoevaluationstudy AT aboelmagdnohafawzy pivotalroleofacitretinnanovesiculargelforeffectivetreatmentofpsoriasisexvivoinvivoevaluationstudy AT elsheakhahmedramadan pivotalroleofacitretinnanovesiculargelforeffectivetreatmentofpsoriasisexvivoinvivoevaluationstudy AT hamedmohammedfawzy pivotalroleofacitretinnanovesiculargelforeffectivetreatmentofpsoriasisexvivoinvivoevaluationstudy AT abdelgawadabdelgawadhelmy pivotalroleofacitretinnanovesiculargelforeffectivetreatmentofpsoriasisexvivoinvivoevaluationstudy |